Tags Parsortix

Tag: Parsortix

Premium

ANGLE moves towards Parsortix FDA approval

Andrew Hore - 28/09/2020 0

Cancer diagnostics developer ANGLE (LON: AGL) is getting nearer to FDA approval for its Parsortix liquid biopsy test. Angle would be the first company...

AstraZeneca shares up on cancer drug approval

Shares Bronte Carvalho - 18/01/2021 0

Shares at British-Swedish pharmaceutical firm AstraZeneca (LON:AZN) have climbed nearly 1% after it announced that US regulatory bodies have approved the use of its...

ESG ETFs grew by 223% in 2020

News Bronte Carvalho - 18/01/2021 0

2020 was something of a boom year for ETFs, which saw the sector grow to $189bn and record almost 200 new listings, after capturing...

CPP Group shares surge on strong trading

Shares Safiya Bashir - 18/01/2021 0

CPP Group shares have surged almost 54% on Monday after the group shared a trading for the year ended 31 December 2020. The group said...

BT shares down on £600m compensation claim